Apply for an Invasive Fungal Disease Fellowship
The Gilead UK & Ireland Fellowship Programme started in 2009. The aim of the Programme is to support local innovation and best practice in patient care in HIV, viral hepatitis, oncology/haematology, respiratory and invasive fungal disease. The Programme invites applications from healthcare or allied professionals who are seeking funding for a project that aligns with the goals of the Gilead UK & Ireland Fellowship Programme.
Applicants are required to demonstrate how their innovative, high-impact project meets the specified, measurable
criteria in order to be awarded funding. Successful applicants are expected to communicate progress of their
project, and to present their findings at the end of the funding period.
Since its inception, the Gilead UK & Ireland Fellowship Programme has supported over 150 projects in the areas
of HIV, viral hepatitis, respiratory and invasive fungal disease. Since 2009 this has left an important legacy
within the research areas funded.
The Gilead UK and Ireland Fellowship Programme awards financial grants to individual organisations or groups of
healthcare providers within a locality, such as, but not limited to, hospital trusts, Charities involved in public
health or health provision, Clinical Commissioning Groups (CCGs not applicable in ROI), Health Boards and Health
Offices responsible for providing, planning or commissioning clinical services in groups for specific therapy area
topics.
The Fellowship Programme does not support projects that meet the EUDRACT criteria of an interventional or
non-interventional study. If you are seeking support for a study, please contact your local Gilead Medical
Scientist. Gilead UK & Ireland Corporate Contributions does not support projects which meet these criteria.
Apply for an Invasive Fungal Disease Fellowship/ Medical Grants Programme The IFD Fellowship/Medical Grants Programme for 2021 is now closed for applications. Please register your details through the link below to be emailed when the application process reopens. |
Please note, in order to comply with EFPIA and country Codes of Practice, Gilead publicly discloses grant support made to patient organisations and healthcare organisations via its website and ABPI/IPHA websites (as applicable). Specifically, details of all successful grantees from Gilead UK & Ireland Corporate Contributions are published on an annual basis. The details will include the name of the organisation, a brief description of the activity and, the amount of support provided.
Gilead UK & Ireland Corporate Contributions Global change
